Spark Therapeutics adds COO to management team
Mr. Furey has 25 years of experience in developing and implementing operational strategies and leading commercial and technical teams.
Prior to joining Spark Therapeutics, Mr. Furey was senior vice president and head of global operations for Baxalta, where he directed manufacturing, quality, engineering, and process development.
He led the team that coordinated and delivered the successful establishment of Baxalta through a spin out from Baxter and led the Baxter Vaccine inline business.
Mr. Furey also spent two years in China as general manager of Pfizer's vaccine business unit following a role with responsibility for global pricing and reimbursement at Pfizer Vaccines.
Earlier in his career, he held both commercial and operations positions of increasing scope and responsibility with Pfizer and Wyeth Pharmaceuticals.
Mr. Furey has an executive M.B.A. from St. Joseph's University, Philadelphia , a B.S. from Trinity College, Dublin, and a diploma in Environmental Health from the Dublin Institute of Technology. ■
LATEST MOVES FROM Pennsylvania
- PPG elects Gary R. Heminger to board
- DICK'S Sporting Goods appoints Scott Hudler as CMO
- First National Bank of Pennsylvania appoints Barbara Cottrell as VP
- Andrew B. Cohen joins Republic First Bancorp board
- Lannett Company appoints Patrick G. LePore to board
More inside POST